Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DW27CA
|
|||
| Drug Name |
Talineuren
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-10: F02.3, G20; ICD-9: 332] | Phase 1 | [1] | |
| Company |
InnoMedica Schweiz AG
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04976127) Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.